Characteristics of early-onset hematotoxicity of sunitinib in Japanese patients with renal cell carcinoma

BACKGROUND: A high incidence of severe hematological adverse events during sunitinib treatment complicates decision making on dose and treatment cycle. We identified the characteristics of early-onset hematotoxicity of sunitinib in Japanese patients with renal cell carcinoma (RCC). METHODS: Seventy-...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Renpei, Kato, Yoichiro, Matsuura, Tomohiko, Kanehira, Mitsugu, Takata, Ryo, Obara, Wataru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364685/
https://www.ncbi.nlm.nih.gov/pubmed/28335742
http://dx.doi.org/10.1186/s12885-017-3205-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364685/
https://www.ncbi.nlm.nih.gov/pubmed/28335742
http://dx.doi.org/10.1186/s12885-017-3205-9

Ejemplares similares